Stanford University scientists found instead of the current guidelines that call for administering the clot-busting drug within three hours of a stroke, it may be effective as much as four-and-a-half hours after a stroke. But one of the lead authors of the tissue Plasminogen Activator study said every minute is important, and the findings indicated the drug's effectiveness drops the longer the time between the stroke and its use.

Related Summaries